CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+9.06%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$14.6B
AUM Growth
+$2.59B
(+22%)
Cap. Flow
+$828M
Cap. Flow
% of AUM
5.67%
Top 10 Holdings %
Top 10 Hldgs %
21.92%
Holding
968
New
130
Increased
364
Reduced
334
Closed
74
Top Buys
| 1 |
Microsoft
MSFT
|
$144M |
| 2 |
Royal Bank of Canada
RY
|
$123M |
| 3 |
Agilent Technologies
A
|
$78.5M |
| 4 |
UnitedHealth
UNH
|
$71.8M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$70.8M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$92.6M |
| 2 |
Amgen
AMGN
|
$87.9M |
| 3 |
Allstate
ALL
|
$52.7M |
| 4 |
PayPal
PYPL
|
$47.9M |
| 5 |
Bio-Rad Laboratories Class A
BIO
|
$47.4M |
Sector Composition
| 1 | Healthcare | 33.43% |
| 2 | Technology | 23.21% |
| 3 | Consumer Discretionary | 9.15% |
| 4 | Financials | 8.64% |
| 5 | Communication Services | 7.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Huntington Bancshares
HBAN
$25.7B
| $10.6M | 0.07% |
741,771
+474,940
| +178% | +$6.78M |
|
277
RadNet
RDNT
$5.49B
| $10.4M | 0.07% |
+309,211
| New | +$10.4M |
|
278
Cytokinetics
CYTK
$6.34B
| $10.2M | 0.07% |
513,344
+137,491
| +37% | +$2.72M |
|
|
IGMS
279
DELISTED
IGM Biosciences
IGMS
| $10.2M | 0.07% |
122,029
+13,137
| +12% | +$1.09M |
|
280
Zoetis
ZTS
$67.9B
| $10M | 0.07% |
53,816
+18,437
| +52% | +$3.44M |
|
281
American Tower
AMT
$92.9B
| $10M | 0.07% |
37,018
-37,858
| -51% | -$10.2M |
|
282
Blackrock
BLK
$170B
| $9.98M | 0.07% |
11,403
-7,407
| -39% | -$6.48M |
|
283
Beam Therapeutics
BEAM
$2.11B
| $9.93M | 0.07% |
+77,147
| New | +$9.93M |
|
284
Dollar General
DG
$24.1B
| $9.84M | 0.07% |
45,475
-19,687
| -30% | -$4.26M |
|
285
Pacific Biosciences
PACB
$381M
| $9.81M | 0.07% |
+280,431
| New | +$9.81M |
|
286
Olema Pharmaceuticals
OLMA
$570M
| $9.78M | 0.07% |
349,572
+349,559
| +2,688,915% | +$9.78M |
|
287
Twist Bioscience
TWST
$1.55B
| $9.71M | 0.07% |
+72,841
| New | +$9.71M |
|
288
Rigel Pharmaceuticals
RIGL
$742M
| $9.64M | 0.07% |
+222,170
| New | +$9.64M |
|
|
CNST
289
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $9.46M | 0.06% |
280,008
-131,507
| -32% | -$4.44M |
|
|
ORBC
290
DELISTED
ORBCOMM, Inc.
ORBC
| $9.46M | 0.06% |
+841,269
| New | +$9.46M |
|
291
GE Aerospace
GE
$296B
| $9.32M | 0.06% |
138,909
-11,011
| -7% | -$739K |
|
292
Quest Diagnostics
DGX
$20.5B
| $9.3M | 0.06% |
70,495
+14,485
| +26% | +$1.91M |
|
293
Mondelez International
MDLZ
$79.9B
| $9.3M | 0.06% |
148,972
-228
| -0.2% | -$14.2K |
|
|
ZGNX
294
DELISTED
Zogenix, Inc.
ZGNX
| $9.28M | 0.06% |
536,758
-327,768
| -38% | -$5.66M |
|
295
Y-mAbs Therapeutics
YMAB
$390M
| $9.26M | 0.06% |
178,181
-1,764
| -1% | -$91.7K |
|
296
ManpowerGroup
MAN
$1.91B
| $9.24M | 0.06% |
+77,722
| New | +$9.24M |
|
297
Toronto Dominion Bank
TD
$127B
| $9.13M | 0.06% |
130,125
-12,788
| -9% | -$897K |
|
298
Intercontinental Exchange
ICE
$99.8B
| $9.12M | 0.06% |
76,862
+39,563
| +106% | +$4.7M |
|
299
Diageo
DEO
$61.3B
| $9.06M | 0.06% |
18,046
+18,038
| +225,475% | +$9.05M |
|
300
BioMarin Pharmaceuticals
BMRN
$11.1B
| $9M | 0.06% |
107,843
-250,187
| -70% | -$20.9M |
|